iiinova — where your digital self keeps evolving

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 02/10/2026

No one should have to choose between their health and paying their bills. We're pleased to see the Government of PEI investing in affordable access to prescription drugs, helping more people get the care they need and easing the financial burden of cancer. www.princeedwardisland.ca/en/news/help...

princeedwardisland.ca

Radware Page

Loader page.

032

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 25/09/2026

Our advocacy team was pleased to attend the 107th International Plowing Match and meet with MPPs across party lines to share our priorities for all Ontarians. We spoke to them about our calls to ensure stability in the Canada Health Transfer, the importance of OHIP coverage for PSA testing and THCD.

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 09/09/2026

Outdated prostate cancer screening guidance could be standing in the way of earlier detection. Alongside partners across Canada, we’re urging a review of national recommendations to reflect today’s evidence and help save lives. Read more and take action: www.theglobeandmail.com/canada/artic...

001

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 27/07/2026

À la suite des rencontres du #Conseildelafédération qui ont eu lieu la semaine dernière, une chose est claire: les soins de santé restent une priorité pour les premiers ministres de partout au Canada. Pour la SCC, le cancer doit faire partie de ces discussions.

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 27/07/2026

As we reflect on last week's Council of the Federation meetings in PEI, one thing is clear: healthcare remains a top priority for Premiers across Canada. For the Canadian Cancer Society, these conversations must include cancer. Canadians are waiting too long for diagnosis, treatment and care.

111

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 24/07/2026

Les recommandations du Groupe de travail sur le secteur des produits pharmaceutiques et des sciences de la vie reflètent celles du Plan d'action relatif aux essais cliniques sur le cancer de la SCC et appuient nos efforts pour améliorer l'accès aux médicaments pour les personnes atteintes de cancer.

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 24/07/2026

We welcome the pharmaceutical and Life sciences sector task force report. Its recommendations align closely with the findings in the Canadian Cancer society's clinical trials action plan and our advocacy to improve access to medications for people with cancer. (1/2)

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 24/07/2026

Une NOUVELLE série d'avertissements sanitaires illustrés fait son apparition sur les paquets de cigarettes dans tout le Canada. Une mesure efficace pour réduire le tabagisme. #cdnpoli

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 22/07/2026

NEW set of graphic health warnings on cigarette packages hit stores across Canada. An effective measure to reduce smoking. #cdnpoli

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 29/06/2026

Today @peigov.bsky.social took meaningful steps on prevention with its new alcohol strategy. Alcohol is a risk factor for at least 9 cancers, including breast and colorectal. Reducing alcohol-related harms can lower cancer risk and help create healthier communities across PEI.

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 23/06/2026

We welcome introduction of the private member’s motion of NDP health critic Gord Johns, calling for a national ban on flavours in e-cigarettes, a measure that would protect Canadian youth!

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 12/06/2026

CCS welcomes Canada’s new AI strategy priorities for healthcare and connected health data. Investments that prioritize AI in health can help strengthen clinical trials and accelerate new discoveries, improve care delivery, and support better outcomes for people across Canada. #AIForAll

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 12/06/2026

Today, New Brunswick's Job Protected Leave legislation achieved Royal Ascent, making it the final Canadian province to pass JPL legislation! Our CCS staff and volunteers were honoured to meet Premier @susanholtnb.bsky.social and congratulate her on this achievement.

000

Reposted by Advocacy at CCS - Défense de l'intérêt public SCC

Canadian Cancer Society @cancersociety.bsky.social · 12/06/2026

Today, New Brunswick joins fellow provinces in protecting the jobs of people facing serious illness like cancer. That means #JobProtectedLeave is in place across every province, so more Canadians can take time to treat and recover without fear of losing their job 💛 Read more: bit.ly/3S40Q2w

012

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 11/06/2026

We were so pleased to meet with MP @bencarrwpg.bsky.social to discuss the economic benefits in streamlining Canada's clinical trial infrastructure!

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 04/06/2026

A big thank you to MP Saini for a productive conversation on cancer control and the importance of strengthening supports like the caregiver tax credit.

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 04/06/2026

We appreciated the opportunity for our Advocacy staff and ACT Leads to meet with Cumberland—Colchester MP Alana Hirtle . We discussed important cancer control issues that would be beneficial locally and Canada-wide. Thank you for your time MP Hirtle!

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 28/05/2026

Yesterday, we were pleased to stand in support of MPP @francempp.bsky.social Bill: Vaping is Not For Kids alongside @heartandstroke.bsky.social. Cancer advocate Taaha shared how his cancer diagnosis as a youth motivated him to advocate to protect youth from tobacco and vaping harms.

120

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 26/05/2026

Wonderful to meet with MP Burton Bailey, representing Red Deer, Alberta, to discuss our Clinical Trial Action Plan. We look forward to working together to strengthen access to innovative, potentially life-saving clinical trials treatments for people in Canada.

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 07/05/2026

Today, we celebrate Canada's largest province moving forward to reduce the screening age for colorectal cancer to 45, following PEI We setting the stage for the remaining provinces and territories to do the same!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

This April, the Canadian Cancer Society held it's 4th Annual Summit and Hill Day to highlight the need for investment into clinical trials in Canada. We heard from our CEO Andrea Seale, Health Minister Marjorie Michel and many others. Thank you to everyone who made it a success!

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

During our day on Parliament Hill in April, our team had the honour of speaking with MP John Zerucelli about investing in Canada's clinical trial infrastructure. Thank you for your time MP Zerucelli!

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, our team had the pleasure of meeting MP Will Stevenson to discuss the importance of accessing cancer clinical trials in Canada. Thank you for your time MP Stevenson!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

While on Parliament Hill, our team had the pleasure of speaking with MP Eric St. Pierre about the importance of clinical trial infrastructure and how we can continue to serve Canadians affected by cancer. Thank you for your time and support MP St. Pierre!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

During Daffodil Month, our Advocacy volunteers had the wonderful opportunity to speak with MP Pauline Rochefort on the importance of clinical trials in Canada. Thank you for your time and support MP Rochefort!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

While in Ottawa, our team was able to speak with MP Sean Casey about the importance of clinical trials in Canada and how we can work together to support Canadians affected by cancer. Thank you for your time MP Casey!

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

This Daffodil Month, we had the pleasure of speaking with MP Sandra Cobena to discuss the importance of accessible cancer care in Canada. Thank you for your time MP Cobena!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

While on Parliament Hill, our team had the opportunity to meet with MP Philip Earle to discuss the importance of accessible clinical trials in Canada. Thank you MP Earle!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, our team had the pleasure of meeting with MP @patrickbweiler.bsky.social in Ottawa to speak about how we can best support Canadians facing cancer. Thank you MP Weiler!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

During our day on Parliament Hill, we had the opportunity to meet with MP Mike Barrett to discuss clinical trial infrastructure and how we can best support Canadians affected by cancer. Thank you for your time MP Barrett!

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Our team had the wonderful opportunity to meet with MP Louis Plamondon on Parliament Hill to discuss clinical trial infrastructure in Canada. Thank you for your time MP Plamondon!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, our advocacy team had the honour of meeting with MP @kristinatesser.bsky.social to discuss cancer care in Canada. Thank you MP Tesser Derksen for your time and the productive conversation!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Thank you MP @honjudysgro.bsky.social for the productive conversation on improving access to cancer care in Canada. We appreciate your time and ongoing support for CCS!

010

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

This Daffodil Month, our team had the pleasure of meeting with MP Guillaume Deschênes-Thériault to discuss the importance of cancer clinical trials in Canada. MP Deschênes-Thériault, it was so wonderful to speak with you and we value your support!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, our team had the pleasure of meeting with MP Peter Fragiskatos to discuss cancer care in Canada and how we can improve our clinical trial infrastructure for those who need it most. Thank you MP Fragiskatos!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Thank you MP Eric Duncan for the productive conversation on how we can work together to better support Canadians affected by cancer!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

While in Ottawa, CCS advocacy volunteer Kelly was able to chat with her MP Burton Bailey about her experience with cancer care and the importance of clinical trials in Canada. Thank you for your time MP Bailey!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, our team had the pleasure of meeting with MP Kathy Borrelli to talk about supporting Canadians affected by cancer and increasing access to clinical trials throughout Canada. Thank you for your time MP Borrelli!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

This Daffodil Month, we had the pleasure of speaking with MP Adam Chambers on the importance of clinical trial infrastructure in Canada and how we can support Canadians in accessing the cancer care they need. Thank you for your time MP Chambers!

100

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Thank you MP Gurbux Saini for your thoughtful discussion on cancer care in Canada and enthusiasm in supporting Canadians affected by cancer!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

While in Ottawa, our team had the pleasure of speaking with MP Chris Malette on the importance of cancer care in Canada and how we can improve access to Clinical Trials. Thank you for your time MP Malette!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

In April, we had the pleasure of meeting with MP Brad Redekopp on Parliament Hill to discuss the importance of clinical trials to Canadians affected Cancer and how we can work together to improve access to them. Thank you MP Redelopp!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

Recently, we had the pleasure of meeting with MP Sukhman Gill to discuss the impact that clinical trials have on Canadians affected by cancer and how we can make them more accessible. Thank you MP Gill!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

At our recent Day on the Hill, we had the chance to speak with MP Tom Osborne about clinical trial infrastructure in Canada. Thank you for your time MP Osborne!

000

Advocacy at CCS - Défense de l'intérêt public SCC @ccsadvocacy.bsky.social · 05/05/2026

This Daffodil Month, our team had the pleasure of speaking with MP Dan Albas about cancer care, clinical trials and how we can work together to serve Canadians affected by cancer. Thank you for your continued support MP Albas!

000

Reposted by Advocacy at CCS - Défense de l'intérêt public SCC

HealthCareCAN @healthcarecan.bsky.social · 21/04/2026

TY @cancersociety.bsky.social for inviting us to your Parliamentary Lunchtime Reception. #ClinicalTrials are core health infrastructure. They strengthen Canada’s research & innovation advantage and help position us as a more competitive place to invest & grow. #CDNPoli @ottawahospital.on.ca

021